SimulConsult is a developer of diagnostic decision support software based in the United States. They provide solutions which cover three main functionalities:
Clinical Diagnostic Decision Support: Uses signs, symptoms, and clinical knowledge from a peer-reviewed database to suggest tests and present a differential diagnosis as shown in the image below.
Loss of Heterozygosity: Supports the analysis of microarrays.
Genome-Phenome Analyzer: Analyzes and reports on whole exome and genome testing.
By using SNOMED CT in the electronic reports generated by their software, SimulConsult has been able to achieve improved interoperability with other systems and EHRs.
Diseases in SimulConsult are linked to (OMIM), a catalog of Human Genes and Genetic Disorders, and additional knowledge resources from the National Library of Medicine (NLM). Tests are linked to "gene test advice" , provided by the NLM . Much of the frequency-based information is based on content. It is also possible to assess a diagnosis based on the patient’s findings, which indicates the frequency as well as the absence or presence of findings.
Although SimulConsult does not use SNOMED CT codes to drive decision support logic, their solution links to SNOMED CT through mappings provided by SimulConsult's terminology partner, (IMO). IMO assigns proprietary codes to findings and diseases, which are then mapped to SNOMED CT. SimulConsult can be configured to use SNOMED CT terms to display and in the outputs of their software, such as patient summaries or genome analysis reports.